Is It Time To Reassess STAAR Surgical (STAA) After Prolonged Share Price Weakness?

Simply Wall St.01-07

If you are wondering whether STAAR Surgical's current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value. The stock is trading ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601640388?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-01-07 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601640388","market":"us","top_or_hot":-1,"title":"Is It Time To Reassess STAAR Surgical (STAA) After Prolonged Share Price Weakness?","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether STAAR Surgical's current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value. The stock is trading ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/is-it-time-to-reassess-staar-surgical-staa-after-prolonged-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess STAAR Surgical (STAA) After Prolonged Share Price Weakness?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess STAAR Surgical (STAA) After Prolonged Share Price Weakness?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-07 22:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/is-it-time-to-reassess-staar-surgical-staa-after-prolonged-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether STAAR Surgical's current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value. The stock is trading ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/is-it-time-to-reassess-staar-surgical-staa-after-prolonged-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DCF","symbol_name":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/is-it-time-to-reassess-staar-surgical-staa-after-prolonged-s","article_id":"2601640388","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/is-it-time-to-reassess-staar-surgical-staa-after-prolonged-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2601640388","pubTimestamp":1767796445,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether STAAR Surgical's current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value.\nThe stock is trading at US$22.29 after a 4% decline over the last 7 days, with returns of a 12.2% decline over 30 days, a 5.6% decline year to date, a 6.7% decline over 1 year, a 66.7% decline over 3 years and a 75.1% decline over 5 years. This naturally raises questions about risk and potential reward.\nRecent news...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","BK4198":"医疗保健用品","STAA":"STAAR Surgical Company"},"translate_title":"股价长期疲软后，是时候重新评估STAAR Surgical(STAA)了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"STAA":1.5},"content_text":"If you are wondering whether STAAR Surgical's current share price reflects its true worth, you are not alone. This article walks through what the numbers are saying about value. The stock is trading at US$22.29 after a 4% decline over the last 7 days, with returns of a 12.2% decline over 30 days, a 5.6% decline year to date, a 6.7% decline over 1 year, a 66.7% decline over 3 years and a 75.1% decline over 5 years. This naturally raises questions about risk and potential reward. Recent news coverage has largely focused on STAAR Surgical's position within the healthcare sector and its specialty in vision correction technology, giving investors more context around the business behind the share price moves. Commentary has also highlighted how sentiment around growth stocks in general can influence companies like STAAR, which helps frame the recent performance you are seeing on the chart. On our valuation checks, STAAR Surgical scores 2 out of 6 on perceived undervaluation, giving it a value score of 2. Next we will compare different valuation approaches before finishing with a broader way to think about what this score really means for you as an investor.  STAAR Surgical scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown. AdvertisementApproach 1: STAAR Surgical Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow model takes a series of future cash flow estimates and discounts them back to today, so you can compare that value with the current share price. For STAAR Surgical, the model uses a 2 Stage Free Cash Flow to Equity framework based on cash flow projections. The latest twelve month free cash flow is a loss of about $42.7 million. Analysts provide explicit free cash flow estimates out to 2030, with Simply Wall St extrapolating further years. For 2030, projected free cash flow is $82 million, with intermediate years such as 2026 at $8 million and 2027 at $36 million, all discounted back to today using the DCF method. Putting these discounted projections together gives an estimated intrinsic value of about $38.54 per share. Against a current share price of $22.29, the DCF output implies the stock is 42.2% undervalued based on these cash flow assumptions. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests STAAR Surgical is undervalued by 42.2%. Track this in your watchlist or portfolio, or discover 877 more undervalued stocks based on cash flows. STAA Discounted Cash Flow as at Jan 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for STAAR Surgical. Approach 2: STAAR Surgical Price vs Sales For many healthcare companies that are not focusing on profits yet, the P/S ratio is often a useful way to think about value because it links the share price to the revenue the business is generating today. In general, higher growth expectations or lower perceived risk can justify a higher P/S ratio, while slower expected growth or higher risk usually call for a lower, more conservative multiple. So you are really asking what level of P/S feels reasonable for this particular business. STAAR Surgical currently trades on a P/S of 4.81x. That sits above the Medical Equipment industry average of 3.12x and above the peer group average of 3.43x. Simply Wall St’s Fair Ratio framework estimates a company specific P/S of 3.59x, which it calls the Fair Ratio. This metric adjusts for factors such as earnings growth, profit margins, industry, market cap and identified risks, so it can be more tailored than a simple comparison with peers or the broad industry. Comparing the Fair Ratio of 3.59x with the current 4.81x suggests the shares are trading at a richer level than that tailored benchmark. Result: OVERVALUED NasdaqGM:STAA P/S Ratio as at Jan 2026 P/S ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1448 companies where insiders are betting big on explosive growth. Upgrade Your Decision Making: Choose your STAAR Surgical Narrative Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St’s Community page you can use Narratives, where you tell your story about STAAR Surgical in plain language, link that story to your own revenue, earnings and margin assumptions, and see how those assumptions roll into a forecast and Fair Value. You can then compare that Fair Value with the current price to help decide whether STAAR looks attractive or not, with the numbers updating automatically when new news or earnings arrive. For example, one investor might build a bullish Narrative that aligns with fair value around US$50 per share and stronger earnings expectations, while another might lean on the more cautious analyst price target of US$16 and weaker earnings. Both can clearly see how their different views on the business lead to very different fair values. Do you think there's more to the story for STAAR Surgical? Head over to our Community to see what others are saying! NasdaqGM:STAA 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601640388","isCrawlerRequest":true}